A Dynamic and Growing Community
In 2014, Gilead established a subsidiary in Hong Kong. Our Hong Kong office is home to a highly skilled and dedicated team that embodies our mission. This team share our commitment to innovation, patient advocacy, and health equity. Along the way, we have walked alongside patients, transforming life by combining science and innovation. We collaborate closely with government agencies and patient organizations to create a healthier community.
Gilead has always been a pioneer, developing a comprehensive care journey in the fight against HIV, from prevention to treatment. We have also introduced a cure for hepatitis C and treatments for COVID-19, addressing emerging infectious diseases that threaten public health. In 2023, we officially ventured into the field of cancer treatment, aiming to address more unmet medical needs.
"Creating possible" is not just Gilead's belief; it is the mission of every employee. With a strong foundation and a diverse culture of home-grown talent, we will continue to our partners to deliver innovative therapies and strive for a healthier community in both markets.
Awards and Recognition
Gilead is proud to have been recognized for our efforts in promoting equity and fostering an inclusive culture in the workplace, as well as for our achievements in addressing health challenges.
- Ranked #1 pharma company for overall corporate reputation in the PatientView 2022 Report, excelling in high-quality patient information, integrity and providing services to patients during COVID-19 and engaging patients in research and development
- Listed in the 2023 Hong Kong LGBT+ Inclusion Index for the second time as the only pharma company to be included in the index
- Awarded the “Caring Company” in 2024 by the Hong Kong Council of Social Service in recognition of our contributions in the areas of “Caring for the Community”, “Caring for the Employees” and “Caring for the Environment”